article · Results in Chemistry
Cucumis ficifolius A.Rich . (Cucurbitaceae) is a popular hedge plant in Ethiopia traditionally been used against malaria, diarrhea, teeth-ach, wounds, burns, stomach ache, meningitis and cancer. The n -hexane and EtOAc extract of the leaves, stems, fruits and roots after silica gel column chromatography afford nine compounds identified as lignoceric acid (1) , α -spinasterol (2), cucurbitacin B (3) , cucurbitacin D (4) , eicosane (5) , stearic acid (6) , 12-hydroxyoctacosa-9,13-dienoic acid (7) , 13-hydroxyoctadeca-9,11-dienoic acid ( 8) and kuguaglycoside E -3-acetate ( 9) . The extracts and isolated compounds displayed broad range of antibacterial activity against all tested bacterial pathogens. The n -hexane extract of root of C. ficifolius A.Rich . exhibited the highest IZD of 14.00 ± 0.10 mm, against P. aeruginosa, at 400 μg/mL. Compound 2 displayed highest IZD of 15.00 ± 0.10 mm, against P. aurogonosa at 400 μg/mL. The extracts were evaluated for their cytotoxicity using MTT assay against MCF-7 breast cancer cell lines. The results revealed that methanol extract of the leaves of C. ficifolius showed promising result compared to the other extracts with IC 50 = 10.48 μg/mL . The DPPH radical scavenging activity shown that the EtOAc extract of roots and compound 9 exhibited better DPPH radical with IC 50 values of 7.24 μg/mL and 4.83 μg/mL, respectively. Compounds 3 and 4 displayed binding affinity of −9.1 − 9.8 kcal/mol against S. aureus DNA gyrase respectively. The binding affinities of compounds 2 was found to be −9.6 kcal/mol against human topoisomerase IIβ. Most of the isolated compounds obeyed Lipinski's rule of five.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.rechem.2026.103154
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.